In modern aesthetic medicine, face and body contouring and the repair of abnormal tissue are no longer limited to traditional liposuction or surgical excision. Advances in minimally invasive aesthetic techniques and biotechnology have made professional fat-dissolving and scar-reduction injections a popular option, offering effective treatment with minimal downtime.
These treatments target two common concerns: stubborn localized fat and fibrotic scar tissue caused by injury or surgery. Administered through subcutaneous microinjections, the formulations are delivered directly to the target tissue. They are designed to stimulate cellular metabolism, break down abnormally cross-linked collagen, and promote remodeling of deeper connective tissue.
Here, we take a closer look at two prominent advanced injectable systems: Spain’s RRS® HA Cellutrix, designed to target localized fat while helping tighten the skin, and PB Serum, a recombinant bio-enzyme formulation intended for the treatment of longstanding, hardened scars, raised or depressed areas, and tissue fibrosis. Both feature innovative formulations intended to offer an alternative to surgery for those seeking smoother contours and softer, more even-textured skin.
Active Ingredients & Technology :
RRS HA Cellutrix is a subcutaneous injection complex designed for localized fat metabolism and connective tissue remodeling. It features a “4+2 complex formula”:
4 metabolic actives: Saponins, Fucoxanthin, L‑Carnitine, Caffeine
2 anti-inflammatory/antioxidant actives: Polyphenols, Flavonoids
Micro non‑crosslinked hyaluronic acid is used as the delivery vehicle. The formulation contains no PPC (Phosphatidylcholine), reducing the risk of tissue necrosis and inflammation.
Mechanism of Action :
Lipolysis & Transport
Caffeine and L‑Carnitine stimulate triglyceride hydrolysis and transport free fatty acids to the mitochondria for β‑oxidation.
Microcirculation & Anti‑edema
Saponins and flavonoids enhance microcirculation and promote drainage of tissue fluids and metabolic waste.
Dermal Firming
Hyaluronic acid and antioxidants help prevent skin laxity and unevenness following fat reduction.
Clinical Indications :
Localized stubborn subcutaneous fat (double chin, upper arms, abdomen, thighs).
Localized contouring and firming with mild edema or reduced connective tissue tension.
A professional injectable recombinant enzyme treatment system developed by the Spanish biotechnology company Proteos Biotech.
Unlike conventional hyaluronic acid fillers or traditional fat-dissolving injections, this treatment uses recombinant enzyme technology to target and help remodel and repair deep-seated scar tissue, fibrotic fat, and hardened tissue adhesions following surgery.
Active Ingredients & Technology :
PB Serum uses lyophilized recombinant enzyme technology. Key components include:
Collagenase PB220: Degrades pathological or hyperplastic collagen fibers.
Lyase PB72K: Breaks down extracellular matrix polysaccharides, improving edema and tissue viscosity.
Lipase PB500: Reduces excess local lipids while protecting cell membranes.
HMW‑HA: Forms a moisture barrier to prevent tissue re‑adhesion.
Mechanism of Action :
Enzymatic Remodeling
Recombinant enzymes precisely cleave disorganized, cross‑linked scar collagen, softening hardened tissues.
Matrix Depolymerization
Breaks down fibrotic adhesions from trauma or surgery, reducing tension and promoting healthy collagen remodeling.
Clinical Indications :
Old hardened scars, hypertrophic scars, localized fibrosis.
Subcutaneous nodules, unevenness, and deep adhesions after surgery or liposuction.
Copyright 2008-2025, Yan’s Group. All rights reserved. 「Disclaimer」